These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 31277978)

  • 21. Open Chromatin Profiling in hiPSC-Derived Neurons Prioritizes Functional Noncoding Psychiatric Risk Variants and Highlights Neurodevelopmental Loci.
    Forrest MP; Zhang H; Moy W; McGowan H; Leites C; Dionisio LE; Xu Z; Shi J; Sanders AR; Greenleaf WJ; Cowan CA; Pang ZP; Gejman PV; Penzes P; Duan J
    Cell Stem Cell; 2017 Sep; 21(3):305-318.e8. PubMed ID: 28803920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional Genomics Identify a Regulatory Risk Variation rs4420550 in the 16p11.2 Schizophrenia-Associated Locus.
    Chang H; Cai X; Li HJ; Liu WP; Zhao LJ; Zhang CY; Wang JY; Liu JW; Ma XL; Wang L; Yao YG; Luo XJ; Li M; Xiao X
    Biol Psychiatry; 2021 Feb; 89(3):246-255. PubMed ID: 33246552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optical Genome Mapping Reveals Genomic Alterations upon Gene Editing in hiPSCs: Implications for Neural Tissue Differentiation and Brain Organoid Research.
    Gallego Villarejo L; Gerding WM; Bachmann L; Hardt LHI; Bormann S; Nguyen HP; Müller T
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards Precision Medicine With Human iPSCs for Cardiac Channelopathies.
    Wu JC; Garg P; Yoshida Y; Yamanaka S; Gepstein L; Hulot JS; Knollmann BC; Schwartz PJ
    Circ Res; 2019 Aug; 125(6):653-658. PubMed ID: 31465267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unlocking the treasure trove: from genes to schizophrenia biology.
    McCarthy SE; McCombie WR; Corvin A
    Schizophr Bull; 2014 May; 40(3):492-6. PubMed ID: 24674812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of homozygous CRISPRa human induced pluripotent stem cell (hiPSC) lines for sustained endogenous gene activation.
    Schoger E; Argyriou L; Zimmermann WH; Cyganek L; Zelarayán LC
    Stem Cell Res; 2020 Oct; 48():101944. PubMed ID: 33038615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Publicly Available hiPSC Lines with Extreme Polygenic Risk Scores for Modeling Schizophrenia.
    Dobrindt K; Zhang H; Das D; Abdollahi S; Prorok T; Ghosh S; Weintraub S; Genovese G; Powell SK; Lund A; Akbarian S; Eggan K; McCarroll S; Duan J; Avramopoulos D; Brennand KJ
    Complex Psychiatry; 2021 Feb; 6(3-4):68-82. PubMed ID: 34883504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Massively parallel techniques for cataloguing the regulome of the human brain.
    Townsley KG; Brennand KJ; Huckins LM
    Nat Neurosci; 2020 Dec; 23(12):1509-1521. PubMed ID: 33199899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR Del/Rei: a simple, flexible, and efficient pipeline for scarless genome editing.
    Feuer KL; Wahbeh MH; Yovo C; Rabie E; Lam AN; Abdollahi S; Young LJ; Rike B; Umamageswaran A; Avramopoulos D
    Sci Rep; 2022 Jul; 12(1):11928. PubMed ID: 35831384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accelerating glioblastoma drug discovery: Convergence of patient-derived models, genome editing and phenotypic screening.
    O'Duibhir E; Carragher NO; Pollard SM
    Mol Cell Neurosci; 2017 Apr; 80():198-207. PubMed ID: 27825983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome editing of human pancreatic beta cell models: problems, possibilities and outlook.
    Balboa D; Prasad RB; Groop L; Otonkoski T
    Diabetologia; 2019 Aug; 62(8):1329-1336. PubMed ID: 31161346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR/Cas9 in zebrafish: an efficient combination for human genetic diseases modeling.
    Liu J; Zhou Y; Qi X; Chen J; Chen W; Qiu G; Wu Z; Wu N
    Hum Genet; 2017 Jan; 136(1):1-12. PubMed ID: 27807677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient generation of hiPSC neural lineage specific knockin reporters using the CRISPR/Cas9 and Cas9 double nickase system.
    Li S; Xue H; Long B; Sun L; Truong T; Liu Y
    J Vis Exp; 2015 May; (99):e52539. PubMed ID: 26065872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The genomics of schizophrenia: Shortcomings and solutions.
    Zhuo C; Hou W; Li G; Mao F; Li S; Lin X; Jiang D; Xu Y; Tian H; Wang W; Cheng L
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jul; 93():71-76. PubMed ID: 30904563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Editing the genome of hiPSC with CRISPR/Cas9: disease models.
    Bassett AR
    Mamm Genome; 2017 Aug; 28(7-8):348-364. PubMed ID: 28303292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling Neuropsychiatric and Neurodegenerative Diseases With Induced Pluripotent Stem Cells.
    LaMarca EA; Powell SK; Akbarian S; Brennand KJ
    Front Pediatr; 2018; 6():82. PubMed ID: 29666786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISPR-Cas9-Edited SNCA Knockout Human Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons and Their Vulnerability to Neurotoxicity.
    Inoue S; Nishimura K; Gima S; Nakano M; Takata K
    Biol Pharm Bull; 2023; 46(3):517-522. PubMed ID: 36858582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using hiPSCs to model neuropsychiatric copy number variations (CNVs) has potential to reveal underlying disease mechanisms.
    Flaherty EK; Brennand KJ
    Brain Res; 2017 Jan; 1655():283-293. PubMed ID: 26581337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studying Kidney Disease Using Tissue and Genome Engineering in Human Pluripotent Stem Cells.
    Garreta E; González F; Montserrat N
    Nephron; 2018; 138(1):48-59. PubMed ID: 28988229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.